Literature DB >> 19521248

Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa.

Isaac M Kigozi1, Loren M Dobkin, Jeffrey N Martin, Elvin H Geng, Winnie Muyindike, Nneka I Emenyonu, David R Bangsberg, Judith A Hahn.   

Abstract

BACKGROUND: Access to free antiretroviral therapy in sub-Saharan Africa has been steadily increasing, and the success of large-scale antiretroviral therapy programs depends on early initiation of HIV care. However, little is known about the stage at which those infected with HIV present for treatment in sub-Saharan Africa.
METHODS: We conducted a cross-sectional analysis of initial visits to the Immune Suppression Syndrome Clinic of the Mbarara University Teaching Hospital, including patients who had their initial visit between February 2007 and February 2008 (N = 2311).
RESULTS: The median age of the patients was 33 years (range 16-81 years), and 64% were female. More than one third (40%) were categorized as late presenters, that is, World Health Organization disease stage 3 or 4. Male gender, age 46-60 years (vs. younger), lower education level, being unemployed, living in a household with others, being unmarried, and lack of spousal HIV status disclosure were independently associated with late presentation, whereas being pregnant, having young children, and consuming alcohol in the prior year were associated with early presentation.
CONCLUSIONS: Targeted public health interventions to facilitate earlier entry into HIV care are needed, as well as additional study to determine whether late presentation is due to delays in testing vs. delays in accessing care.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521248      PMCID: PMC2815238          DOI: 10.1097/QAI.0b013e3181ab6eab

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  58 in total

1.  Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.

Authors:  Stephen D Lawn; Landon Myer; Guy Harling; Catherine Orrell; Linda-Gail Bekker; Robin Wood
Journal:  Clin Infect Dis       Date:  2006-08-08       Impact factor: 9.079

2.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

3.  Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania.

Authors:  G Antelman; M C Smith Fawzi; S Kaaya; J Mbwambo; G I Msamanga; D J Hunter; W W Fawzi
Journal:  AIDS       Date:  2001-09-28       Impact factor: 4.177

4.  Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men.

Authors:  K Manavi; A McMillan; M Ogilvie; G Scott
Journal:  Int J STD AIDS       Date:  2004-12       Impact factor: 1.359

5.  Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy.

Authors:  E Girardi; A Sampaolesi; M Gentile; G Nurra; G Ippolito
Journal:  J Acquir Immune Defic Syndr       Date:  2000-09-01       Impact factor: 3.731

6.  Abolition of cost-sharing is pro-poor: evidence from Uganda.

Authors:  J Nabyonga; M Desmet; H Karamagi; P Y Kadama; F G Omaswa; O Walker
Journal:  Health Policy Plan       Date:  2005-03       Impact factor: 3.344

7.  HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa.

Authors:  S C Kalichman; L C Simbayi
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

8.  Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence.

Authors:  Jesús Castilla; Paz Sobrino; Luis De La Fuente; Isabel Noguer; Luis Guerra; Francisco Parras
Journal:  AIDS       Date:  2002-09-27       Impact factor: 4.177

9.  The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection.

Authors:  H B Krentz; M C Auld; M J Gill
Journal:  HIV Med       Date:  2004-03       Impact factor: 3.180

10.  Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns.

Authors:  Sheri D Weiser; Michele Heisler; Karen Leiter; Fiona Percy-de Korte; Sheila Tlou; Sonya DeMonner; Nthabiseng Phaladze; David R Bangsberg; Vincent Iacopino
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

View more
  102 in total

1.  HIV in Africa: Challenges and Directions for the Next Decade.

Authors:  Bruce L Gilliam; Devang Patel; Rohit Talwani; Zelalem Temesgen
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

2.  A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa.

Authors:  Elvin H Geng; David V Glidden; David R Bangsberg; Mwebesa Bosco Bwana; Nicholas Musinguzi; Denis Nash; John Z Metcalfe; Constantin T Yiannoutsos; Jeffrey N Martin; Maya L Petersen
Journal:  Am J Epidemiol       Date:  2012-02-03       Impact factor: 4.897

3.  Late presentation to HIV/AIDS testing, treatment or continued care: clarifying the use of CD4 evaluation in the consensus definition.

Authors:  S MacCarthy; D R Bangsberg; G Fink; M Reich; S Gruskin
Journal:  HIV Med       Date:  2013-09-11       Impact factor: 3.180

4.  Predictors of CD4 eligibility for antiretroviral therapy initiation among HIV-infected pregnant women in Lusaka, Zambia.

Authors:  Katherine C Liu; Jessica Mulindwa; Mark J Giganti; Nande B Putta; Namwinga Chintu; Benjamin H Chi; Jeffrey S A Stringer; Elizabeth M Stringer
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

5.  Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.

Authors:  Denis Nash; Yingfeng Wu; Batya Elul; David Hoos; Wafaa El Sadr
Journal:  AIDS       Date:  2011-07-31       Impact factor: 4.177

6.  The importance of social ties in sustaining medication adherence in resource-limited settings.

Authors:  Alexander C Tsai; David R Bangsberg
Journal:  J Gen Intern Med       Date:  2011-12       Impact factor: 5.128

Review 7.  Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review.

Authors:  Alexander J Lankowski; Mark J Siedner; David R Bangsberg; Alexander C Tsai
Journal:  AIDS Behav       Date:  2014-07

Review 8.  What Role Do Masculine Norms Play in Men's HIV Testing in Sub-Saharan Africa?: A Scoping Review.

Authors:  Katelyn M Sileo; Rebecca Fielding-Miller; Shari L Dworkin; Paul J Fleming
Journal:  AIDS Behav       Date:  2018-08

9.  Health care utilization and access to human immunodeficiency virus (HIV) testing and care and treatment services in a rural area with high HIV prevalence, Nyanza Province, Kenya, 2007.

Authors:  Marta-Louise Ackers; Allen Hightower; David Obor; Peter Ofware; Lilian Ngere; Adazu Kubaje; Kayla F Laserson
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

10.  Late-stage disease at presentation to an HIV clinic in eastern Tanzania: A retrospective cross-sectional study.

Authors:  H Mhozya; D Bintabara; S Kibusi; E Neilson; B C Mpondo
Journal:  Malawi Med J       Date:  2015-12       Impact factor: 0.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.